Cynthia Challener and Danielle Alvarez of Pharma’s Almanac discuss the innovative processes that plasmid DNA manufacturers are developing to overcome key manufacturing challenges and meet rising demand for plasmids as critical raw materials for the production of viral vector-, mRNA-, and DNA-based therapeutics.
.svg)
